The Isolated Form of Rapid Eye Movement Sleep Behavior Disorder: The Upcoming Challenges.
Study Goal
The researchers aimed to evaluate the need for alternative treatments for REM sleep behavior disorder (RBD) when current options like melatonin and clonazepam fail or cause side effects.
Results Summary
The abstract states that melatonin ameliorates RBD symptoms but highlights the need for therapeutic alternatives when it fails or produces side effects. No specific efficacy data or statistical results are provided.
Population
Patients with isolated REM sleep behavior disorder (RBD), particularly those at risk for synucleinopathies like Parkinson's disease and dementia with Lewy bodies.
Effective Dosage
Not specified
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
Clonazepam | decrease | RBD symptoms | - | - | ameliorate | #1 |
melatonin | decrease | RBD symptoms | - | - | ameliorate | #2 |
The diagnosis of rapid eye movement (REM) sleep behavior disorder (SBD) requires videopolysomnography detection of excessive electromyographic activity during REM sleep, which is time consuming and difficult. An easier, faster, reliable, and reproducible methodology is needed for its diagnosis. The isolated form of RBD represents an early manifestation of the synucleinopathies Parkinson disease and dementia with Lewy bodies. There is a need to find neuroprotective drugs capable of preventing parkinsonism and dementia onset in isolated RBD. Clonazepam and melatonin ameliorate the RBD symptoms, but therapeutic alternatives are needed when these medications fail or show produce side effects.